Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

被引:0
|
作者
Alice Indini
Lorenza Di Guardo
Carolina Cimminiello
Michele Prisciandaro
Giovanni Randon
Filippo De Braud
Michele Del Vecchio
机构
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology
[2] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Department of Medical Oncology and Hematology
[3] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Università degli studi di Milano
关键词
Melanoma; Immunotherapy; Anti-PD1; IrAEs; Vitiligo; Toxicity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:511 / 521
页数:10
相关论文
共 50 条
  • [21] THYROID IMMUNE-RELATED ADVERSE EVENTS ARE ASSOCIATED WITH IMPROVED SURVIVAL IN CANCER PATIENTS
    Abdallah, Duaa
    Goldner, Whitney
    Johnosn, Jake
    Kotwal, Anupam
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (07) : 1584 - 1584
  • [22] Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma
    Dawidowska, Anna
    Jagodzinska-Mucha, Paulina
    Kosela-Paterczyk, Hanna
    Jaczewska, Sylwia
    Sobczuk, Pawel
    Chelstowska, Monika
    Kowalska, Maria
    Badziak-Sterczewska, Honorata
    Poleszczuk, Jan
    Rutkowski, Piotr
    Lugowska, Iwona
    CANCERS, 2022, 14 (05)
  • [23] Prognostic significance of immune-related adverse events and immunosuppression in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Karapetyan, Lilit
    Bruno, Sabrina
    Abushukair, Hassan Mohammed
    Bo, Na
    Wang, Hong
    Sander, Cindy
    Kirkwood, John M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    McCulloch, John A.
    Davar, Diwakar
    Rodrigues, Richard R.
    Badger, Jonathan H.
    Fang, Jennifer R.
    Cole, Alicia M.
    Balaji, Ascharya K.
    Vetizou, Marie
    Prescott, Stephanie M.
    Fernandes, Miriam R.
    Costa, Raquel G. F.
    Yuan, Wuxing
    Salcedo, Rosalba
    Bahadiroglu, Erol
    Roy, Soumen
    DeBlasio, Richelle N.
    Morrison, Robert M.
    Chauvin, Joe-Marc
    Ding, Quanquan
    Zidi, Bochra
    Lowin, Ava
    Chakka, Saranya
    Gao, Wentao
    Pagliano, Ornella
    Ernst, Scarlett J.
    Rose, Amy
    Newman, Nolan K.
    Morgun, Andrey
    Zarour, Hassane M.
    Trinchieri, Giorgio
    Dzutsev, Amiran K.
    NATURE MEDICINE, 2022, 28 (03) : 545 - +
  • [25] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    John A. McCulloch
    Diwakar Davar
    Richard R. Rodrigues
    Jonathan H. Badger
    Jennifer R. Fang
    Alicia M. Cole
    Ascharya K. Balaji
    Marie Vetizou
    Stephanie M. Prescott
    Miriam R. Fernandes
    Raquel G. F. Costa
    Wuxing Yuan
    Rosalba Salcedo
    Erol Bahadiroglu
    Soumen Roy
    Richelle N. DeBlasio
    Robert M. Morrison
    Joe-Marc Chauvin
    Quanquan Ding
    Bochra Zidi
    Ava Lowin
    Saranya Chakka
    Wentao Gao
    Ornella Pagliano
    Scarlett J. Ernst
    Amy Rose
    Nolan K. Newman
    Andrey Morgun
    Hassane M. Zarour
    Giorgio Trinchieri
    Amiran K. Dzutsev
    Nature Medicine, 2022, 28 : 545 - 556
  • [26] Purple papules during anti-PD1 immunotherapy for metastatic melanoma
    De Luca, Erika V.
    Catapano, Silvia
    Del Regno, Laura
    Di Stefani, Alessandro
    Peris, Ketty
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (04): : 630 - 632
  • [27] Development of endocrine immune-related adverse events and improved survival in advanced melanoma patients treated with nivolumab monotherapy
    Maeda, Takuya
    Yoshino, Koji
    Nagai, Kojiro
    Oaku, Satoe
    Kato, Megumi
    Hiura, Azusa
    Hata, Hiroo
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 13 - 16
  • [28] Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects
    Vitek, Grace
    Hansra, Harjot
    NEUROLOGY, 2023, 100 (17)
  • [29] Experience of immune-related adverse events associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center
    Rapoport, B. L.
    Smit, T.
    Van Eeden, R. I.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Immunotherapy - immune-related adverse events and their management
    Petrausch, Ulf
    THERAPEUTISCHE UMSCHAU, 2019, 76 (04) : 195 - 198